ATE392218T1 - Stabilisierte 99mtc zusammensetzung - Google Patents

Stabilisierte 99mtc zusammensetzung

Info

Publication number: ATE392218T1
Authority: AT; Austria
Prior art keywords: 99mtc; tetrofosmin; stabilized; composition; lyophilised
Prior art date: 2004-12-15

Application number

AT05794253T

Other languages

English (en)

Inventor

Grethe Martinussen

Gry Stensrud

Ole Hjelstuen

Original Assignee

Ge Healthcare Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-15

Filing date

2005-10-14

Publication date

2008-05-15

2005-10-14 Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE392218T1 publication Critical patent/ATE392218T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 4
229960004113 tetrofosmin Drugs 0.000 abstract 3
235000010323 ascorbic acid Nutrition 0.000 abstract 2
239000011668 ascorbic acid Substances 0.000 abstract 2
230000000845 anti-microbial effect Effects 0.000 abstract 1
239000004599 antimicrobial Substances 0.000 abstract 1
229940072107 ascorbate Drugs 0.000 abstract 1
229960005070 ascorbic acid Drugs 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
239000002184 metal Substances 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1
230000002335 preservative effect Effects 0.000 abstract 1
229940121896 radiopharmaceutical Drugs 0.000 abstract 1
239000012217 radiopharmaceutical Substances 0.000 abstract 1
230000002799 radiopharmaceutical effect Effects 0.000 abstract 1
229940124553 radioprotectant Drugs 0.000 abstract 1
QCWJONLQSHEGEJ-UHFFFAOYSA-N tetrofosmin Chemical compound CCOCCP(CCOCC)CCP(CCOCC)CCOCC QCWJONLQSHEGEJ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Optics & Photonics (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Saccharide Compounds (AREA)
Lock And Its Accessories (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Noodles (AREA)
Train Traffic Observation, Control, And Security (AREA)
Devices For Supply Of Signal Current (AREA)

AT05794253T 2004-12-15 2005-10-14 Stabilisierte 99mtc zusammensetzung ATE392218T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0427392.6A GB0427392D0 (en)	2004-12-15	2004-12-15	Stabilised 99mTc compositions

Publications (1)

Publication Number	Publication Date
ATE392218T1 true ATE392218T1 (de)	2008-05-15

Family

ID=34090037

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05794253T ATE392218T1 (de)	2004-12-15	2005-10-14	Stabilisierte 99mtc zusammensetzung

Country Status (17)

Country	Link
US (1)	US9694092B2 (de)
EP (1)	EP1824525B1 (de)
JP (1)	JP5064236B2 (de)
KR (1)	KR101297523B1 (de)
CN (2)	CN103028123A (de)
AT (1)	ATE392218T1 (de)
AU (1)	AU2005315503B2 (de)
BR (1)	BRPI0518636B8 (de)
CA (1)	CA2590620C (de)
DE (1)	DE602005006157T2 (de)
ES (1)	ES2306219T3 (de)
GB (1)	GB0427392D0 (de)
MX (1)	MX2007007223A (de)
NO (1)	NO340538B1 (de)
PL (1)	PL1824525T3 (de)
RU (1)	RU2403067C2 (de)
WO (1)	WO2006064175A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2654369C (en) *	2006-06-21	2014-10-14	Ge Healthcare Limited	Radiopharmaceutical products
US20100056826A1 (en) *	2006-11-09	2010-03-04	Nihon Medi-Physicis Co., Ltd.	Radioactive diagnostic imaging agent
GB0718386D0 (en) *	2007-09-21	2007-10-31	Ge Healthcare As	Improved radiopharmaceutical formulation
RU2463075C1 (ru) *	2011-07-01	2012-10-10	Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации	СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
RU2512595C1 (ru) *	2013-01-09	2014-04-10	Федеральное государственное бюджетное учреждение "Научно-исследовательский институт онкологии" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИ онкологии" СО РАМН)	СПОСОБ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ ПРИГОТОВЛЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ 99-m НАНОКОЛЛОИДА НА ОСНОВЕ ГАММА-ОКСИДА АЛЮМИНИЯ
RU2543654C1 (ru) *	2013-11-29	2015-03-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет"	СПОСОБ ПОЛУЧЕНИЯ МЕЧЕННОГО ТЕХНЕЦИЕМ-99m НАНОКОЛЛОИДА
EP2899195A1 (de)	2014-01-28	2015-07-29	ROTOP Pharmaka AG	Stabilisierte Form von Tetrofosmin und seine Verwendung
WO2017059092A1 (en)	2015-09-30	2017-04-06	Duke University	Ascorbate formulations and methods of use as contrast agents
IT201600101875A1 (it) *	2016-10-11	2018-04-11	Advanced Accelerator Applications Int S A	Composizioni liofilizzate comprendenti rhAnnexin V-128, processo per la loro preparazione e loro uso per la preparazione di formulazioni contenenti 99mTc-rhAnnexin V-128
KR20190128545A (ko) *	2017-03-08	2019-11-18	주빌런트 제네릭스 리미티드(포멀리 어 디비젼 오브 주빌런트 라이프 사이언시스 리미티드)	테트로포스민 또는 그것의 산 부가 염의 제조를 위한 개선된 과정
BR112020005243A2 (pt) *	2017-11-23	2020-09-24	Jubilant Generics Limited (Formerly A Division Of Jubilant Life Sciences Limited)	composição farmacêutica compreendendo tetrofosmina e sais farmaceuticamente aceitáveis da mesma
BR112020005524A2 (pt) *	2018-10-06	2020-10-06	Jubilant Generics Limited	composições farmacêuticas de enxofre coloidal e processos das mesmas
CN116059409A (zh) *	2022-12-01	2023-05-05	程毓渡	一种新型心脏造影和评价心室的锝-99m治疗诊断剂及评价方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA761944B (en)	1975-04-30	1977-03-30	Procter & Gamble	Stable radiographic scanning agents
JPS5750928A (en) *	1980-09-13	1982-03-25	Nippon Mejifuijitsukusu Kk	Diagnostic agent for scanning bone
JPS5896031A (ja) *	1981-12-03	1983-06-07	Nippon Mejifuijitsukusu Kk	放射性診断剤およびその製造用組成物
GB8808414D0 (en) *	1988-04-11	1988-05-11	Amersham Int Plc	Ligands & cationic complexes thereof with technetium-99m
JP2860157B2 (ja)	1990-10-31	1999-02-24	日本メジフィジックス株式会社	腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5300280A (en) *	1992-02-14	1994-04-05	Mallinckrodt Medical, Inc.	Stabilized radiopharmaceutical kits
EP1197227B9 (de) *	1999-06-21	2008-06-11	Nihon Medi-Physics Co., Ltd.	Verfahren zur verabreichung von arzneimitteln mit bindungsaffinität zum plasmaprotein und verwendung der zusammensetzung in dem verfahren
CN1184225C (zh) *	2000-06-28	2005-01-12	北京师范大学	一种替曲膦季鏻盐及其制法和二步法替曲膦药盒及其应用
GB0031592D0 (en) *	2000-12-28	2001-02-07	Nycomed Amersham Plc	Stabilised radiopharmaceutical compositions
CZ20032597A3 (cs) *	2001-02-26	2004-12-15	Bristol-Myers Squibb Pharma Company	Analogy kyseliny askorbové pro metaloradiofarmaceutika
GB0116815D0 (en) *	2001-07-10	2001-08-29	Nycomed Amersham Plc	Improved chelator conjugates

2004
- 2004-12-15 GB GBGB0427392.6A patent/GB0427392D0/en not_active Ceased
2005
- 2005-10-14 ES ES05794253T patent/ES2306219T3/es not_active Expired - Lifetime
- 2005-10-14 RU RU2007120467/15A patent/RU2403067C2/ru active
- 2005-10-14 US US11/721,064 patent/US9694092B2/en active Active
- 2005-10-14 WO PCT/GB2005/003975 patent/WO2006064175A1/en not_active Ceased
- 2005-10-14 CN CN2012104649695A patent/CN103028123A/zh active Pending
- 2005-10-14 MX MX2007007223A patent/MX2007007223A/es active IP Right Grant
- 2005-10-14 DE DE602005006157T patent/DE602005006157T2/de not_active Expired - Lifetime
- 2005-10-14 AU AU2005315503A patent/AU2005315503B2/en not_active Ceased
- 2005-10-14 EP EP05794253A patent/EP1824525B1/de not_active Expired - Lifetime
- 2005-10-14 BR BRPI0518636A patent/BRPI0518636B8/pt not_active IP Right Cessation
- 2005-10-14 AT AT05794253T patent/ATE392218T1/de not_active IP Right Cessation
- 2005-10-14 KR KR1020077013340A patent/KR101297523B1/ko not_active Expired - Fee Related
- 2005-10-14 JP JP2007546154A patent/JP5064236B2/ja not_active Expired - Lifetime
- 2005-10-14 PL PL05794253T patent/PL1824525T3/pl unknown
- 2005-10-14 CN CNA2005800430653A patent/CN101107017A/zh active Pending
- 2005-10-14 CA CA2590620A patent/CA2590620C/en not_active Expired - Lifetime
2007
- 2007-06-20 NO NO20073158A patent/NO340538B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN103028123A (zh)	2013-04-10
NO340538B1 (no)	2017-05-02
BRPI0518636B8 (pt)	2021-07-27
BRPI0518636B1 (pt)	2016-12-13
CA2590620C (en)	2012-12-04
EP1824525B1 (de)	2008-04-16
MX2007007223A (es)	2007-08-14
RU2007120467A (ru)	2009-01-27
PL1824525T3 (pl)	2008-11-28
KR20070089156A (ko)	2007-08-30
WO2006064175A1 (en)	2006-06-22
CN101107017A (zh)	2008-01-16
AU2005315503A1 (en)	2006-06-22
BRPI0518636A2 (pt)	2008-12-02
CA2590620A1 (en)	2006-06-22
US9694092B2 (en)	2017-07-04
GB0427392D0 (en)	2005-01-19
AU2005315503B2 (en)	2011-06-02
DE602005006157D1 (de)	2008-05-29
DE602005006157T2 (de)	2009-05-28
KR101297523B1 (ko)	2013-08-16
JP2008524178A (ja)	2008-07-10
US20110008252A9 (en)	2011-01-13
ES2306219T3 (es)	2008-11-01
RU2403067C2 (ru)	2010-11-10
US20090311178A1 (en)	2009-12-17
EP1824525A1 (de)	2007-08-29
JP5064236B2 (ja)	2012-10-31
NO20073158L (no)	2007-07-04

Legal Events

Date	Code	Title	Description
2008-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
NO20073158L (no)	2007-07-04	Stabiliserte 99mTC-sammensetninger
TNSN07341A1 (en)	2008-12-31	Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
MX2007002398A (es)	2007-05-15	Nuevas composiciones farmaceuticas para el tratamiento de cancer.
TW200800967A (en)	2008-01-01	Benzimidazole thiophene compounds
BRPI0508579A (pt)	2007-08-14	composto, composição farmacêutica, e, uso de um composto
DK1951729T3 (da)	2014-10-06	Oxygenbundne pyrimidinderivater
WO2006012527A8 (en)	2006-03-09	Bivalent linkers and conjugates thereof
CL2009000906A1 (es)	2010-04-09	Compuestos derivados de 4-imidazolil y 4-triazolil de 2-(6-(4-cicloalquilpiperazin-1-il)pirimidin-4-il)-1h-pirazol-3(2h)ona inhibidores de hif-prolil-4-hidroxilasas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de enfermedades cardiovasculares, renales y hematologicas.
NO20074737L (no)	2007-11-14	Isokinolinforbindelser og fremgangsmater for anvendelse derav
WO2008134013A3 (en)	2009-05-07	Pharmaceutical excipient complex
GEP20084452B (en)	2008-08-10	Sulfonamide derivatives for the treatment of diseases
WO2012168885A3 (en)	2013-01-31	Bisacodyl and its analogues as drugs for use in the treatment of cancer
WO2007022255A3 (en)	2007-06-14	Pharmaceutical formulations for sustained release
MX2009000768A (es)	2009-01-28	Lactamas macrociclicas.
DE602006020295D1 (de)	2011-04-07	Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel
WO2009013358A3 (en)	2009-10-22	Polysaccharides grafted by polyamines for the preparation of radiopharmaceutical compositions
EA200701172A1 (ru)	2007-10-26	2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200800993A (en)	2008-01-01	Organic compounds
WO2006088903A3 (en)	2007-05-10	Pyrazole compounds
WO2007056236A3 (en)	2007-09-20	Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
UA87312C2 (ru)	2009-07-10	КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ
TW200718698A (en)	2007-05-16	Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
WO2007087026A3 (en)	2007-09-13	Solid-state form of amg 706 and pharmaceutical compositions thereof
MX2009005182A (es)	2009-05-25	Derivados de 2-hidroxi-1,3-diamino-propano.
SI1720540T1 (sl)	2008-12-31	Satraplatin za zdravljenje rezistentnih ali refraktornih tumorjev